-
Global Molecular Diagnostics Market Set to Reach USD 30.74 Billion by 2030 | MarketsandMarkets™
13 Nov 2025 15:58 GMT
… , DiaSorin S.p.A., Myriad Genetics, Agilent Technologies, Exact Sciences … Care Molecular Diagnostics Market
Molecular Infectious Disease Testing Market
Molecular Cytogenetics … Top Companies in Molecular Diagnostics and Molecular Diagnostics Market Size
…
-
Global Molecular Diagnostics Market Set to Reach USD 30.74 Billion by 2030 | MarketsandMarkets™
13 Nov 2025 14:30 GMT
… , DiaSorin S.p.A., Myriad Genetics, Agilent Technologies, Exact Sciences … Care Molecular Diagnostics Market
Molecular Infectious Disease Testing Market
Molecular Cytogenetics … Top Companies in Molecular Diagnostics and Molecular Diagnostics Market Size
…
-
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
11 Nov 2025 14:00 GMT
… -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing … myriad.com. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
10 Nov 2025 13:30 GMT
… ) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing … any way.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
06 Nov 2025 13:30 GMT
… -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic … the conference. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025
27 Oct 2025 20:15 GMT
… ) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing … the call. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel
14 Oct 2025 12:00 GMT
… -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing … ethnicities.4
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics and Sophia Genetics partner to develop a global liquid biopsy companion test
30 Sep 2025 15:10 GMT
Myriad Genetics, a specialist in molecular diagnostic testing and precision medicine, … .
Sam Raha, president and CEO, Myriad Genetics, said, "Serving patients and … is a strategic focus for Myriad Genetics. We expect this collaboration with …
-
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
23 Sep 2025 12:00 GMT
… ) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing … looking statements. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … for all. Myriad Genetics develops and offers molecular tests that help …
-
Angle announces collaboration with Myriad Genetics for molecular analysis
22 Aug 2025 07:52 GMT
… into a collaboration with Myriad Genetics Inc, a leading molecular diagnostic testing and … matched patient tissue samples using Myriad Genetics' existing tissue-based … look forward to working with Myriad Genetics to progress this collaboration which …
About
© 1995-2025